Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
TS Ross, VE Mgbemena - Molecular & cellular oncology, 2014 - Taylor & Francis
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
TS Ross, VE Mgbemena - Molecular & cellular oncology, 2014 - pubmed.ncbi.nlm.nih.gov
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
TS Ross, VE Mgbemena - Molecular and …, 2014 - utsouthwestern.elsevierpure.com
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia.
TS Ross, VE Mgbemena - Molecular & Cellular Oncology, 2014 - europepmc.org
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
[HTML][HTML] Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
TS Ross, VE Mgbemena - Molecular & Cellular Oncology, 2014 - ncbi.nlm.nih.gov
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
[引用][C] Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
TS Ross, VE Mgbemena - Molecular & Cellular Oncology, 2014 - cir.nii.ac.jp
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia.
TS Ross, VE Mgbemena - Molecular & Cellular Oncology, 2014 - europepmc.org
Chronic myelogenous leukemia (CML) requires the BCR/ABL tyrosine kinase for disease
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …
onset and maintenance. As a result, CML can be successfully treated with tyrosine kinase …